相关实验视频
Updated: Feb 5, 2026
08:22
Orthotopic Left Lung Transplantation in Rats
Published on: July 3, 2025
755
成功的双边肺移植与多中心卡斯特曼病的长期存活时间,致命的肺部参与
Jianheng Zhang1, Guilin Peng1, Guansheng Su1
1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Transplantation proceedings
|February 3, 2026
概括
这项研究报告了一个罕见的病例,双边肺移植成功治疗了多中心卡斯特曼病 (MCD) 患者的严重呼吸衰竭. 该程序显著改善了患者的肺功能和生活质量.
科学领域:
- 肺部病理学 肺部病理学
- 血液学 血液学 血液学
- 移植手术 移植手术
背景情况:
- 多中心卡斯特曼病 (MCD) 可能导致严重的呼吸道并发症.
- 支气管炎 obliterans 是MCD的一个潜在并发症,导致渐进性呼吸障碍.
- 类固醇治疗可能不足以管理MCD的晚期呼吸衰竭.
研究的目的:
- 为了呈现MCD引起的严重呼吸衰竭病例.
- 评估双边肺移植在治疗这种并发症方面的疗效.
- 突出肺移植作为MCD相关呼吸衰竭的治疗选择.
主要方法:
- 一个31岁的男性患者的病例报告,患有MCD和呼吸衰竭.
- 移植前评估肺功能和大头.
- 手术干预:双边肺移植.
- 移植后的随访,包括肺功能和氧气需求评估.
主要成果:
- 这位患者出现了渐进的呼吸不全,严重的头过度,以及由于MCD和支气管炎 obliterans导致的肺功能受损.
- 双边肺移植导致显著缓解高头症.
- 肺功能在移植后显著改善.
- 移植后四年,患者还活着,不需要氧气,并且表现出持续的功能改善.
结论:
- 双边肺移植可以为多中心卡斯特曼病中严重呼吸衰竭提供拯救生命和有效的治疗方法.
- 这一案例强调了肺移植在管理MCD相关的晚期肺部并发症方面的潜在作用.
- 肺移植提供了一个可行的治疗策略,当医疗管理不能控制MCD的呼吸道衰退时.
相关概念视频
02:17Ecological Succession
21.5K
Ecological succession is influenced by the processes of facilitation, inhibition, and toleration. Facilitation occurs when early successional species create more favorable ecological conditions for subsequent species, such as enhanced nutrient, water, or light availability. In contrast, inhibition happens when early successional species create unfavorable ecological conditions for potential successive species, such as limiting resource availability. In some cases, later successional species...
21.5K
01:47Lung Capacity
56.3K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.3K
01:24Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.8K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.2K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.5K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.5K